35 results
DEFM14A
PRTK
Paratek Pharmaceuticals, Inc.
2 Aug 23
Proxy related to merger
5:03pm
Matters
A-22
Section 3.21.
Data Privacy
A-23
Section 3.22.
Brokerage
A-24
Section 3.23.
Disclosure
A-24
Section 3.24.
Opinion
A-24
Section 3.25.
CFIUS
PREM14A
PRTK
Paratek Pharmaceuticals, Inc.
30 Jun 23
Preliminary proxy related to merger
9:16am
.
FDA and Regulatory Law Matters
A-22
Section 3.21.
Data Privacy
A-23
Section 3.22.
Brokerage
A-24
Section 3.23.
Disclosure
A-24
Section 3.24.
Opinion … . Data Privacy.
(a) Since the Reference Date, the Company and its Subsidiaries and, to the Knowledge of the Company, all vendors, processors or other
DEFA14A
PRTK
Paratek Pharmaceuticals, Inc.
7 Jun 23
Additional proxy soliciting materials
6:11am
.
FDA and Regulatory Law Matters
Section 3.21.
Data Privacy
Section 3.22.
Brokerage
Section 3.23.
Disclosure
Section 3.24.
Opinion
Section 3.25.
CFIUS … of any investigation, proceeding or other Action relating to any Federal Health Care Program-related offense.
Section 3.21. Data Privacy.
(a) Since
8-K
EX-2.1
PRTK
Paratek Pharmaceuticals, Inc.
7 Jun 23
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings
6:07am
and Labor Matters
Section 3.20.
FDA and Regulatory Law Matters
Section 3.21.
Data Privacy
Section 3.22.
Brokerage
Section 3.23.
Disclosure
Section 3.24 … . Data Privacy.
(a) Since the Reference Date, the Company and its Subsidiaries and, to the Knowledge of the Company, all vendors, processors or other
8-K
EX-10.4
wjz3ie3o9z598596q
4 Jan 21
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.10
886oqjaj2
4 Jan 21
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-10.7
umijllp4px70gsz5o0o5
4 Jan 21
Entry into a Material Definitive Agreement
4:51pm
8-K
EX-1.1
q90w9f0g3n
2 Jul 19
Entry into a Material Definitive Agreement
5:22pm